Role of PRMTs in cancer: Could minor isoforms be leaving a mark?

doi:10.4331/wjbc.v5.i2.115

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5636)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

578

WORD

304

HTML

3245

Figures (1-3)

251

Tables (1-2)

253

Sum=4631

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

400

Download

605

Sum=1005

May 26, 2014 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Biological Chemistry

ISSN

1949-8454

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Biol Chem. May 26, 2014; 5(2): 115-129
Published online May 26, 2014. doi: 10.4331/wjbc.v5.i2.115

Full Size Figure Download Figure

Figure 1 Arginine methylation reactions catalyzed by protein arginine methyltransferases. Type I protein arginine methyltransferases catalyze the asymmetric dimethylation of arginine residues, Type II symmetrically dimethylated arginine and Type III monomethylated arginine residues.

Citation: Baldwin RM, Morettin A, Côté J. Role of PRMTs in cancer: Could minor isoforms be leaving a mark? World J Biol Chem 2014; 5(2): 115-129
URL: https://www.wjgnet.com/1949-8454/full/v5/i2/115.htm
DOI: https://dx.doi.org/10.4331/wjbc.v5.i2.115